MitochondrialResearch
SLU-PP-332
Also known as: ERRγ Agonist
A synthetic ERRγ agonist hailed as an exercise mimetic that replicates endurance training adaptations without physical exertion.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~4–8 hours
Typical Dose
Research dosing
Administration
Oral or injection
Mechanism of Action
Activates Estrogen-Related Receptor gamma to drive mitochondrial biogenesis, fat oxidation, and type I muscle fiber formation.
Key Research Areas
exercise mimeticendurancemitochondrialERR
Frequently Asked Questions
What is SLU-PP-332?▾
A synthetic ERRγ agonist hailed as an exercise mimetic that replicates endurance training adaptations without physical exertion.
How does SLU-PP-332 work?▾
Activates Estrogen-Related Receptor gamma to drive mitochondrial biogenesis, fat oxidation, and type I muscle fiber formation.
What is the recommended dosage for SLU-PP-332?▾
The typical research dosage is Research dosing, administered via Oral or injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of SLU-PP-332?▾
The half-life of SLU-PP-332 is approximately ~4–8 hours. This affects dosing frequency and timing in research protocols.
Is SLU-PP-332 FDA approved?▾
SLU-PP-332 is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about SLU-PP-332 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.